Skip to main content
. 2018 Jun 4;2018(6):CD009642. doi: 10.1002/14651858.CD009642.pub3

1. Sensitivity analyses ‐ risk of bias (incomplete outcome data).

    All studies Without high/unclear risk of bias studies (incomplete outcome data)
Outcome Statistical method Studies Effect estimate Studies Effect estimate
Pain score, rest, 'early time points' (1 hr to 4 hrs, PACU) SMD (IV, Random, 95% CI) 29 −0.50 (−0.72 to −0.28) 17 −0.45 (−0.77 to −0.14)
Pain score, rest, 'intermediate time points' (24 hrs) SMD (IV, Random, 95% CI) 33 −0.14 (−0.25 to −0.04) 18 −0.12 (−0.26 to 0.01)
Pain score, rest, 'late time points' (48 hrs) SMD (IV, Random, 95% CI) 24 −0.11 (−0.25 to 0.04) 11 −0.06 (−0.27 to 0.15)
Postoperative ileus (dichotomous) RR (MH, Random, 95% CI) 4 0.37 (0.15 to 0.87) 4 0.37 (0.15 to 0.87)
Time to first defaecation/bowel movement (hrs) MD (IV, Random, 95% CI) 12 −7.92 (−12.71 to −3.13) 8 −7.5 (−14.38 to −0.63)
Time to first flatus (hrs) MD (IV, Random, 95% CI) 13 −4.09 (−6.30 to −1.87) 9 −3.98 (−7.03 to −0.93)
Time to first bowel sounds (hrs) MD (IV, Random, 95% CI) 2 −6.08 (−13.77 to 1.60) 2 −6.08 (−13.77 to 1.60)
Length of hospital stay (days) MD (IV, Random, 95% CI) 32 −0.37 (−0.60 to −0.15) 17 −0.23 (−0.49 to 0.02)
Length of hospital stay (outpatient surgery, mins) MD (IV, Random, 95% CI) 3 −10.81 (−36.93 to 15.31) 3 −10.81 (−36.93 to 15.31)
Surgical complications ‐ anastomotic leak RR (MH, Random, 95% CI) 3 0.61 (0.08 to 4.80) 3 0.61 (0.08 to 4.80)
Surgical complications ‐ bleeding RR (MH, Random, 95% CI) 3 1.79 (0.41 to 7.89) 3 1.79 (0.41 to 7.89)
Surgical complications ‐ postoperative infection RR (MH, Random, 95% CI) 5 1.64 (0.41 to 6.52) 4 1.19 (0.25 to 5.67)
Patient satisfaction MD (IV, Random, 95% CI) 6 0.76 (0.46 to 1.06) 2 0.59 (−0.09 to 1.26)
Postoperative nausea, early (PACU) RR (MH, Random, 95% CI) 8 0.72 (0.53 to 0.98) 7 0.66 (0.47 to 0.91)
Postoperative nausea, overall (0 to 24 hrs, to 48 hrs, to 72 hrs) RR (MH, Random, 95% CI) 35 0.78 (0.67 to 0.91) 19 0.87 (0.72 to 1.06)
Postoperative vomiting, early (PACU) RR (MH, Random, 95% CI) 4 0.49 (0.16 to 1.48) 3 0.75 (0.15 to 3.80)
Postoperative vomiting, overall (0 to 24 hrs, to 48 hrs, to 72 hrs) RR (MH, Random, 95% CI) 19 0.83 (0.63 to 1.08) 7 0.88 (0.58 to 1.31)
Intraoperative opioid consumption (MEQ, mg) MD (IV, Random, 95% CI) 18 −2.14 (−3.87 to −0.40) 10 −1.52 (−4.13 to 1.09)
Intraoperative opioid consumption with remifentanil (MEQ, mg) MD (IV, Random, 95% CI) 6 −14.17 (−35.27 to 6.92) 5 −16.08 (−41.41 to 9.25)
Postoperative opioid consumption, PACU (MEQ, mg) MD (IV, Random, 95% CI) 21 −3.10 (−3.87 to −2.32) 12 −2.59 (−3.76 to −1.42)
Postoperative opioid consumption, overall (MEQ, mg) MD (IV, Random, 95% CI) 40 −4.52 (−6.25 to −2.79) 25 −2.84 (−4.45 to −1.22)

Acronyms and abbreviations used in the table:

CI = confidence interval, hrs = hours, IV = inverse variance, MD = mean difference, MEQ = morphine equivalent dose, mins = minutes, MH = Mantel Haenszel, PACU = post anaesthesia care unit, RR = risk ratio, SMD = standardized mean difference